FDA 510(k) Clearance for Varian’s Vitesse™ Brachytherapy Treatment Planning Software



Varian Medical Systems Receives FDA 510(k) Clearance for Vitesse™ Brachytherapy Treatment Planning Software (via PR Newswire)

Tool enables clinicians to plan and perform high-dose-rate (HDR) brachytherapy treatments for prostate cancer using real-time ultrasound guidance PALO ALTO, Calif., Jan. 24, 2013 /PRNewswire/ — Varian Medical Systems (NYSE: VAR) has received an FDA 510(k) clearance for the latest version of its Vitesse…